Systematic design of combination therapy by targeting master regulators of coexisting diffuse midline glioma cell states

This paper identifies the ‘master regulators’ that maintain cell transcriptional states in diffuse midline gliomas and shows that targeting them in combination could represent a promising therapeutic avenue for the disease.